ENTITY

Spero Therapeutics (SPRO US)

2
Analysis
Health CareUnited States
Spero Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on identifying, developing, and commercializing novel treatments for MDR bacterial infections. Spero Therapeutics also offers a technology platform that develops drugs to expand the spectrum and potency of existing antibiotics. Spero Therapeutics serves customers worldwide.
more
04 Nov 2024 23:09Issuer-paid

Biopharma Week in Review - November 4, 2024

Last week, NVO had all semaglutide dosages listed available on the FDA drug shortage list, pressuring compounded GLP-1 seller HIMS.

Logo
149 Views
Share
bullishS&P 500 INDEX
06 May 2020 03:02

U.S. Equities: Upside Momentum Lost, But Not Breaking Down

In today's report we highlight key levels and several metrics we are watching that will provide us clues as to where the S&P 500 is headed...

Logo
434 Views
Share
No more insights
x